Molecular diagnostics company Atonarp has raised US$33m in an oversubscribed Series C round of funding. The Tokyo-based company has attracted five new investors including Japan Post Investment Corporation, SBI Investment, and…
Molecular diagnostics company Atonarp has raised US$33m in an oversubscribed Series C round of funding. The Tokyo-based company has attracted five new investors including Japan Post Investment Corporation, SBI Investment, and…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference